The authors frame their discussion around the two principal classes of plant immune receptors. The first comprises pattern recognition receptors, cell-surface proteins that detect conserved microbial molecules such as bacterial flagellin, elongation factor Tu, and fungal chitin. Landmark structural studies, including the 2013 Science paper on the Arabidopsis FLS2–BAK1 complex activated by the flagellin epitope flg22, revealed how these receptors dimerize with co-receptors to initiate signaling. The second class consists of intracellular nucleotide-binding leucine-rich repeat receptors, or NLRs, which detect pathogen effectors delivered inside host cells. Together these two receptor families form a layered surveillance network that the review treats as an engineering platform rather than a fixed endowment.

A striking theme of the review is how structural biology has transformed receptor engineering from trial and error into rational design. Cryo-electron microscopy structures of activated NLR complexes, including the ZAR1 resistosome, the wheat Sr35 resistosome triggered by the AvrSr35 effector, and the hexameric NRC4 resistosome reported in 2024, showed that many NLRs function as oligomeric calcium-permeable channels. Because activation depends on defined conformational changes, ligand binding and effector recognition interfaces can now be mapped precisely, giving bioengineers specific residues to modify. Machine learning tools such as AlphaFold extend this capability by predicting receptor structures for which experimental structures are unavailable, enabling comparative modeling across large receptor families and the identification of candidate binding surfaces for targeted mutagenesis.

The review documents several concrete engineering successes at the cell-surface layer. Reverse engineering of FLS2, described in Nature Plants in 2025, revealed design principles that broaden recognition spectra against evading flg22 epitopes, while related work unlocked expanded flagellin perception through rational receptor engineering. Domain-swap approaches have a long pedigree here: chimeric receptors combining the extracellular domain of one receptor with the signaling domain of another, such as EFR–Cf-9 and CEBiP–Pi-d2 fusions, have produced enhanced responses to bacterial and fungal pathogens. Engineering of secreted protease co-receptors has converted divergent Rcr3 orthologs into functional immune components, and a 2026 Science study resolved how a damage-sensing receptor recognizes glycans, adding yet another recognition modality to the engineering toolbox.

At the intracellular layer, the review highlights strategies that exploit the modular architecture of NLRs. Many NLRs carry integrated domains that mimic effector targets, functioning as decoys or sensors; engineering these domains, as demonstrated for rice NLR pairs in eLife studies, can expand the profile of recognized effectors. Nanobody–NLR fusions reported in Science in 2023 conferred resistance by coupling synthetic binders to immune activation, effectively programming receptors against arbitrary molecules. Remodeling autoactive NLRs for broad-spectrum immunity, published in Nature in 2025, and a plug-in strategy for resistance engineering inspired by the potato NLRome, published in Nature in 2026, illustrate how both engineered and naturally evolved receptor modules can be recombined. Artificial evolution, from early work extending the spectrum of a potato virus resistance gene to stepwise evolution of the Sw-5b receptor against resistance-breaking tospovirus isolates, remains a complementary approach that does not require detailed structural knowledge.

Transfer of immune receptor genes across species boundaries emerges as one of the most immediately translatable strategies. The Arabidopsis EFR receptor, which recognizes bacterial elongation factor Tu, has been expressed in tomato, potato, rice, wheat, banana, sweet orange, apple, Medicago and citrus, in each case enhancing resistance to bacterial pathogens without disrupting beneficial symbioses in legumes. The rice Xa21 receptor has been deployed in banana and mandarin against Xanthomonas diseases. Interfamily transfer of NLRs has likewise matured: wheat stem rust genes Sr22, Sr33, Sr35 and Sr45 function in barley, and a 2025 Cell paper showed that co-transfer of sensor and helper NLR pairs extends receptor functionality between angiosperms, resolving a long-standing bottleneck in which transferred receptors lacked their required signaling partners.

The review is candid about the central trade-off that constrains all immune engineering: growth versus defense. Constitutive immune activation imposes fitness costs, and the literature on growth–defense trade-offs, surveyed in recent Cell Host & Microbe and Plant Biotechnology Journal commentaries, shows that breeders must balance resistance against yield. Several solutions are highlighted. Upstream open reading frames can tune receptor expression so that defense proteins accumulate only upon infection, an approach shown in Nature in 2017 to confer engineered resistance without fitness costs. Genome editing of susceptibility genes and promoters has produced broad-spectrum resistance in rice and wheat without growth penalties, and targeted protein degradation technologies are being applied to remove condensation-prone immune proteins that otherwise damage the endoplasmic reticulum.

Looking forward, the authors identify CRISPR-based genome editing and artificial intelligence as the technologies most likely to accelerate the field. CRISPR enables precise edits to receptor genes, promoter architecture, and susceptibility targets within elite cultivar backgrounds, bypassing the linkage drag of conventional introgression from wild relatives. AI-assisted protein design, exemplified by atomically accurate de novo antibody design with RFdiffusion reported in Nature in 2026, offers a template for designing synthetic recognition domains with programmable specificity. Machine learning resources such as the NLRexpress motif predictor suite and in silico prediction of NLR–effector interactions are already used to prioritize candidate receptors from the rapidly growing sequence databases generated by resistance gene enrichment sequencing and pan-genome studies.

The review closes with a sober assessment of the translational challenges that stand between laboratory success and agricultural impact. Stacking multiple receptors, as demonstrated with three late blight resistance genes in African highland potato and a five-transgene cassette against wheat rust, is essential for durability because pathogen populations evolve to overcome single genes, but stacking raises regulatory and intellectual property complexities. The authors argue that scalability, regulatory harmonization and equitable access must be addressed in parallel with the science, pointing to initiatives such as the Open Source Seed Initiative as models. By integrating mechanistic insight, structural design and deployment strategy, they contend, plant immune receptor engineering can deliver the environmentally sustainable crop production systems that rising pathogen pressure and a changing climate increasingly demand.

Subject of Research: Engineering of plant pattern recognition receptors and NLR immune receptors for broad-spectrum, durable crop disease resistance

Article Title: Plant immune receptor engineering

Article References: Wang, J., Li, Y., Hong, Y., & Liu, Y. (2026). Plant immune receptor engineering. Nature Reviews Bioengineering. https://doi.org/10.1038/s44222-026-00499-3

Image Credits: AI Generated

DOI: 10.1038/s44222-026-00499-3

Keywords: plant immunity, immune receptors, NLR proteins, pattern recognition receptors, crop biotechnology, resistosome, CRISPR genome editing, AlphaFold, protein engineering, disease resistance, food security, interfamily gene transfer

To appreciate why this matters, it helps to understand how plants normally sense attack. Plants deploy two layers of immune surveillance. The first relies on pattern recognition receptors at the cell surface, which detect generic molecular signatures of microbes. The second, more powerful layer operates inside the cell and depends on intracellular receptors called NLRs, short for nucleotide-binding leucine-rich repeat proteins. NLRs recognize the effectors, virulence proteins that adapted pathogens inject into host cells to suppress defense, and when they do, they trigger effector-triggered immunity, or ETI. This response is famously robust and durable, and it is often marked by a rapid, localized cell death at infection sites known as the hypersensitive response, which sacrifices a few cells to wall off the invader. Intriguingly, some NLRs that mediate antiviral immunity confer extreme resistance without any visible cell death at all. Genetic studies stretching back decades have shown that the majority of classical plant disease resistance genes encode NLR proteins, which is precisely why they have been prized targets for breeders trying to protect staple crops from devastating epidemics.

Structural biology has transformed what is possible with these receptors. Cryo-electron microscopy and biochemical work in recent years revealed that upon effector recognition, activated NLRs assemble into large multi-protein complexes called resistosomes. In the case of the two major sensor classes, CNLs, which carry a coiled-coil domain, and helper NLRs of the RESISTANCE TO POWDERY MILDEW 8-like class, known as RNLs, these resistosomes insert themselves into the plasma membrane and form calcium-permeable channels. The resulting influx of calcium ions into the cell acts as a second messenger that ignites the ETI program. A landmark finding came from the study of an autoactive RNL variant, AtNRG1.1 carrying a D485V substitution, which mimics the activated state and spontaneously oligomerizes into functional calcium channels even without a pathogen cue. Researchers also discovered that the pore-forming activity of CNLs and RNLs depends on a short N-terminal helix within their N-terminal domains, and, crucially, that fusing extra protein sequences to the N-terminus can physically block their ability to trigger immunity. That observation planted the seed for the new engineering strategy.

The design logic is elegant. Wang and colleagues constructed chimeric autoactive NLRs, or aNLRs, by taking an autoactive CNL or RNL and fusing to its N-terminus a blocking peptide linked through a pathogen-originated protease cleavage site, abbreviated PCS. Under normal growing conditions, the blocking peptide suppresses the receptor’s autoactivity, so the plant grows normally with no wasteful immune activation or stunting. Upon infection, proteases secreted or released by the pathogen cleave the PCS, the blocking peptide falls away, and the now-liberated aNLR oligomerizes into calcium-permeable channels, launching a potent immune response exactly where and when it is needed. The pathogen, in effect, pulls the trigger on its own destruction. Because the switch is flipped by an enzymatic activity the pathogen must deploy rather than by recognition of a specific molecular shape, the system sidesteps the evolutionary arms race that usually undermines single-resistance-gene deployments.

The practical demonstrations were striking. The team incorporated a cleavage site, designated PCS-PVY with the sequence YEVHHQ followed by the scissile bond, that is targeted by the NIa proteases encoded by more than 110 potyviruses, a vast virus family that includes some of agriculture’s worst enemies. Transgenic tobacco plants expressing the engineered autoactive form of the CNL Tm-2², tagged as aTm-2², or the autoactive RNL AtNRG1.1, tagged as aAtNRG1.1, each fused behind the PCS-PVY module, displayed complete or extreme resistance against multiple potyviruses. The researchers then broadened the resistance spectrum further by tandemly integrating PCS-PVY with PCS-TEV, the cleavage site for the NIa protease of tobacco etch potyvirus, allowing a single receptor to respond to proteases from an even wider range of viral attackers. Critically, the strategy was not confined to one species: transgenic soybeans expressing an aAtNRG1. construct carrying a soybean mosaic virus-specific cleavage site, PCS-SMV, achieved complete resistance to soybean mosaic virus, a devastating global pathogen responsible for significant yield losses in one of the world’s most important legume crops.

What sets aNLR engineering apart from earlier attempts to reprogram plant immunity is its simplicity and generality. Most current NLR engineering strategies focus on sensor NLRs, trying to alter which effectors they recognize by mutating or swapping domains within the leucine-rich repeat region or in integrated decoy domains that make direct contact with effectors. These approaches demand detailed structural knowledge of NLR-effector complexes, require labor-intensive site-directed modifications at binding interfaces, and carry the constant risk of triggering deleterious autoimmunity if the modifications go wrong. An alternative tactic uses the PBS1 decoy system, in which cleavage of the PBS1 protein by the bacterial effector AvrPphB activates the guard NLR RPS5; substituting different cleavage sites into PBS1 can redirect RPS5 activation toward other pathogens. But that trick only works in plants that naturally possess a similar PBS1-guarding NLR pairing, limiting its portability across species.

The aNLR approach, by contrast, needs only a single autoactive CNL or RNL that tolerates being silenced by an N-terminal fusion, plus a short blocking peptide and a cleavage site to govern activation. Because activation depends on protease cleavage rather than specific effector binding, using a conserved cleavage site recognized by proteases from many related pathogens, or stringing several sites together, readily yields broad-spectrum resistance. Since proteases are ubiquitous among pathogens and pests of every kind, the authors argue the same chassis could, in principle, be retargeted against virtually any pathogen or even insect by simply swapping the cleavage site, potentially extending protection across kingdom boundaries from viruses to fungi to bacteria. Durability is another built-in advantage: if the protease that processes the cleavage site is essential for the pathogen’s virulence or infection cycle, then any mutation that prevents cleavage would simultaneously cripple the pathogen itself, making escape mutations costly or lethal. The pathogen is trapped between an immune response it triggers and a virulence factor it cannot afford to change.

There are also reasons to expect the platform to travel well across the crop universe. CNLs and RNLs are widespread among crop species, and the calcium-channel activity that emerges when they form resistosomes is a conserved mechanism, so the strategy does not depend on the particular genetic background of a recipient cultivar in the way that effector-recognition engineering often does. The editorial’s authors additionally point out that aNLR engineering can be combined with CRISPR/Cas genome editing, allowing breeders to remodel endogenous CNL or RNL genes directly in elite varieties, conditioning their autoactivity in place rather than introducing transgenes. That prospect matters enormously for deployment, because it could compress the years of backcrossing that conventional resistance breeding requires and avoid some of the regulatory and consumer complications associated with transgenic crops, depending on jurisdiction and the exact editing outcome.

Caveats remain, as they always do between a Nature paper and the field. The published demonstrations cover potyviruses in tobacco and soybean mosaic virus in soybean, and extending the platform to other pathogen classes, other crops, and real-world field conditions will require further validation, as will careful agronomic assessment to confirm that the silenced receptors impose no yield penalty and that immune activation is properly contained at infection sites. Nonetheless, the conceptual leap is hard to overstate. Instead of chasing every new pathogen strain with a new resistance gene, breeders could deploy a universal immune tripwire that any pathogen must spring in order to attack, and that it cannot disarm without losing its own virulence. If that vision holds up, the engineering of autoactive NLRs may well be remembered as a turning point in the long war between farmers and the pathogens that pursue their harvests, offering durable, broad-spectrum protection built from the plant’s own deepest immune machinery.

Subject of Research: Engineering of autoactive NLR immune receptors for broad-spectrum and durable disease resistance in crops

Article Title: Engineering of autoactive NLRs: a big step toward breeding crops with durable and broad-spectrum resistance

Article References: Wang, Y., & Xiao, S. (2025). Engineering of autoactive NLRs: a big step toward breeding crops with durable and broad-spectrum resistance. Advanced Biotechnology, 3(3), Article 24. https://doi.org/10.1007/s44307-025-00079-3

Image Credits: AI Generated

DOI: 10.1007/s44307-025-00079-3

Keywords: plant immunity, NLR receptors, autoactive NLRs, effector-triggered immunity, resistosome, broad-spectrum resistance, potyvirus, soybean mosaic virus, protease cleavage site, crop breeding, CRISPR, disease resistance

The receptors in question belong to the nucleotide-binding leucine-rich repeat family, the workhorse intracellular immune sensors of plants. NLR proteins carry a modular architecture: a variable N-terminal signalling domain, a central nucleotide-binding domain that acts as a molecular switch, and a C-terminal leucine-rich repeat domain that serves as the recognition module. In the resting state, the receptor is autoinhibited, folded upon itself. When the leucine-rich repeat domain perceives, directly or indirectly, the presence or activity of a pathogen effector protein, the switch flips, the receptor oligomerises into a resistosome, and a cascade of defensive responses follows, often culminating in a localised cell death that walls off the invader.

The trouble with engineering these receptors has always been the recognition surface. Leucine-rich repeats are exquisitely tuned by evolution to particular effector proteins, and their binding interfaces are diffuse, conformationally dynamic and poorly tolerant of casual mutation. Attempts to retune an existing NLR to recognise a new effector have met with limited success, because the coupling between recognition and activation is idiosyncratic to each receptor. Natural diversity, meanwhile, is finite. When a pathogen delivers an effector for which no plant in the gene pool carries a matching sensor, breeders have no card to play. This is the gap that synthetic receptors are designed to close.

The new approach sidesteps the problem of retuning natural recognition surfaces by building the sensing module afresh. Advances in de novo protein design, accelerated by deep-learning structure prediction tools such as AlphaFold and by generative design methods demonstrated over the past several years, allow researchers to specify a protein binder with a chosen shape and interaction profile and then compute an amino acid sequence that should fold into it. Rather than asking an existing NLR to learn a new partner, the strategy designs a synthetic binder against a defined pathogen effector and wires that binder into an immune receptor scaffold, so that effector binding triggers the conserved activation machinery of the NLR.

Wiring is the crux. A binder that merely sticks to an effector accomplishes nothing unless binding is mechanically transduced into receptor activation. The engineering challenge is therefore one of allostery: the designed recognition domain must be coupled to the nucleotide-binding switch such that the receptor sits stably in its off state in the absence of pathogen, yet flips decisively when the effector is present. Getting this balance wrong in either direction is costly. A receptor that fires without its ligand would impose autoimmune damage and yield penalties, while one that fails to respond leaves the plant defenceless. The design-build-test cycle must therefore evaluate both specificity and the absence of spontaneous activation.

This is where the second half of the strategy, evolution in vivo, earns its place. Computational design produces starting points, not finished products; predicted interfaces routinely require empirical optimisation. Directed evolution, in which libraries of receptor variants are generated and screened for the desired activity, has already proven its worth in plant immunity. Previous work showed that natural NLRs can be turned into robust sensors of specific effectors through targeted mutagenesis of their recognition domains, and that such engineered receptors can be deployed in crops. The synthetic pipeline extends this logic: rather than evolving a natural receptor toward a new specificity, researchers evolve a designed receptor toward reliable function, screening variants in planta for strong responses to the target effector and no response to plant proteins.

The significance of combining these steps is that each compensates for the other’s weakness. De novo design offers unlimited starting diversity, unconstrained by what nature has provided, but its predictions are imperfect. Directed evolution offers empirical optimisation with exquisite sensitivity to function, but it needs a plausible starting scaffold to improve upon. Designed receptors give evolution a head start; evolution gives design its final polish. The result, as the Nature Plants commentary describes it, is on-demand design and refinement of resistance genes: a workflow in which a pathogen effector of agricultural concern can be identified, a synthetic receptor raised against it in silico, and functional variants selected in plants within a timeframe that conventional breeding cannot approach.

The broader context makes the timing notable. Structure prediction has matured to the point that protein complexes and designed binders can be modelled with remarkable fidelity, and generative protein design has produced functional enzymes, sensors and therapeutics in other domains. Plant immunology, meanwhile, has accumulated a detailed mechanistic understanding of how NLRs activate, including structural snapshots of resistosomes that reveal how effector perception is coupled to signalling. The convergence of these threads is what makes synthetic immune receptors plausible now, when the same attempt even five years ago would have lacked both the design tools and the mechanistic template.

There are, of course, substantial hurdles between a working prototype and a deployed resistance gene. Pathogens evolve; an effector targeted by a synthetic receptor can mutate its surface, and durable resistance may require stacking multiple sensors or targeting effectors whose function the pathogen cannot easily relinquish. Regulatory frameworks for crops carrying designed genes, and public acceptance of them, remain open questions. There is also the matter of scale: each new effector target demands its own design and evolution campaign, and the reliability of the pipeline across diverse effector families has yet to be demonstrated broadly. The commentary’s authors, writing from a laboratory with deep roots in plant immunity research, frame the advance as the opening of a route rather than its completion.

Even so, the conceptual shift is hard to overstate. Plant immunity has until now been a scavenging enterprise, drawing on variation that pathogens and plants co-authored over millions of years. If synthetic receptors can be designed against arbitrary pathogen proteins and matured by directed evolution in planta, the defensive repertoire of crops becomes a matter of engineering choice rather than evolutionary inheritance. For a world in which plant diseases claim a substantial share of harvests and climate change keeps redistributing pathogen pressure, the ability to write a resistance gene to order, and to have it refined in the very organisms it will protect, marks a genuine inflection point in how humanity arms its crops.

Subject of Research: Engineering synthetic plant NLR immune receptors through de novo protein design and directed evolution in planta

Article Title: Plant immune receptors built in silico and evolved in vivo

Article References: Jones, J. D. G., & Zhao, H. (2026). Plant immune receptors built in silico and evolved in vivo. Nature Plants. https://doi.org/10.1038/s41477-026-02398-2

Image Credits: AI Generated

DOI: 10.1038/s41477-026-02398-2

Keywords: plant immunity, NLR receptors, de novo protein design, directed evolution, synthetic biology, crop disease resistance, pathogen effectors, protein engineering, plant biotechnology, resistance genes, AlphaFold, resistosome